Sharon Benzeno insider trades

Open-market stock purchases and sales by Sharon Benzeno, Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp, from SEC Form 4 filings since Feb 13, 2020.

Recent trades

DateStockTradeValue
Jun 29, 2026ADPT Adaptive Biotechnologies CorpSold$3.3M
Jun 29, 2026ADPT Adaptive Biotechnologies CorpBought (not open market)—
Jun 29, 2026ADPT Adaptive Biotechnologies CorpBought (not open market)—
Jun 29, 2026ADPT Adaptive Biotechnologies CorpBought (not open market)—
Jun 26, 2026ADPT Adaptive Biotechnologies CorpSold$232K
Jun 26, 2026ADPT Adaptive Biotechnologies CorpBought (not open market)—
Mar 11, 2026ADPT Adaptive Biotechnologies CorpSold$831K
Mar 4, 2026ADPT Adaptive Biotechnologies CorpBought (not open market)—
Dec 4, 2025ADPT Adaptive Biotechnologies CorpSold$212K
Dec 4, 2025ADPT Adaptive Biotechnologies CorpBought (not open market)—
Dec 4, 2025ADPT Adaptive Biotechnologies CorpBought (not open market)—
Nov 21, 2025ADPT Adaptive Biotechnologies CorpSold$5.2M
Nov 21, 2025ADPT Adaptive Biotechnologies CorpBought (not open market)—
Nov 21, 2025ADPT Adaptive Biotechnologies CorpBought (not open market)—
Nov 21, 2025ADPT Adaptive Biotechnologies CorpBought (not open market)—
Nov 21, 2025ADPT Adaptive Biotechnologies CorpBought (not open market)—
Nov 21, 2025ADPT Adaptive Biotechnologies CorpBought (not open market)—
Nov 21, 2025ADPT Adaptive Biotechnologies CorpBought (not open market)—
Nov 20, 2025ADPT Adaptive Biotechnologies CorpSold$4.9M
Nov 20, 2025ADPT Adaptive Biotechnologies CorpBought (not open market)—
Nov 20, 2025ADPT Adaptive Biotechnologies CorpBought (not open market)—

Companies traded

  • ADPT Adaptive Biotechnologies Corp: 50 sales, last Jun 29, 2026

Get free alerts when Sharon Benzeno files a new trade →